News
Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...
CVS Health (CVS) stock in focus as its pharmacy benefit manager CVS Caremark faces $289.9M in damages and penalties for ...
A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...
1don MSN
CVS Caremark ordered to pay $290M after Medicare fraud scheme exposed by former Aetna whistleblower
Whistleblower Sarah Behnke's lawsuit leads to a $290 million judgment against CVS Caremark for overcharging Medicare on ...
A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...
A federal judge has ordered CVS Health's PBM Caremark to pay nearly $290 million after a whistleblower accused the business of overcharging Medicare on prescription drugs more than a decade ago.
A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...
2d
TipRanks on MSNCVS Health (CVS) Ordered to Pay Nearly $290M for Medicare Fraud
Notably, the case came from a whistleblower lawsuit filed by Sarah Behnke, a former Medicare Part D actuary at Aetna, who ...
1d
Stocktwits on MSNCVS Health Reportedly Keeps Gilead’s New HIV Preventative Shot Off Its Plans, Faces $290M Medicare Fraud Ruling
CVS Health, which operates the largest U.S. pharmacy benefit manager, will not add Gilead Sciences’ new HIV prevention drug ...
–CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.– ...
Individuals enrolled in a University of Delaware non-Medicare health plan, administered by Highmark Delaware or Aetna, are automatically enrolled in the University of Delaware prescription plan. CVS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results